IFLb
About IFLb
IFLb is a Healthcare company based in Berlin (Germany), and was acquired by Medicover in January 2024. Medical laboratory providing clinical and research services. Its chief executive, as recorded, is Roman M Skoblo. Its focus areas include Clinical Laboratories. Its legal entity is IFLb Laboratoriumsmedizin Berlin GmbH.
Company details
IFLb is an independent medical laboratory located in Berlin, Germany. They have been providing clinical and research services for over 35 years, with a focus on metabolomics for chronic kidney disease. They offer online test result access and other services through their website.
- Headquarters Berlin, Germany
- Stage Acquired
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website iflb.de/das-labor
- Acquired by Medicover (Jan 2024)
- Legal Name Iflb Laboratoriumsmedizin Berlin Gmbh
Investors in IFLb
IFLb has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Medicover.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Multispeciality hospitals are operated as a chain in healthcare. | 1995 | medicover.com | Warsaw, Poland |
Investor details for IFLb
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of IFLb
2 people are tracked at IFLb (2 in leadership).
| Name | Role | Group |
|---|---|---|
Chantal Gitelman | Managing Director | Leadership |
Roman M Skoblo | CEO | Leadership |
Complete people profiles for IFLb
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Web traffic of IFLb
The website of IFLb (iflb.de) receives about 6.5K visits a month.
- Monthly visits6.5K
▲ 17.4% vs previous month
Websites whose visitors overlap most with IFLb. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
ht-mb.de | ht-mb.de | 100% | #1,172,221 | – | |
probiosdiagnostik.de | probiosdiagnostik.de | 89% | – | ||
bundeswehrkrankenhausberlin.de | bundeswehrkrankenhausberlin.de | 87% | – | ||
kadegroup.de | kadegroup.de | 53% | – | ||
google.de | google.de | 36% | #175 | – |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about IFLb
IFLb is headquartered in Berlin, Germany. It is registered at Berlin, Berlin, Germany.
Roman M Skoblo is the CEO of IFLb, as recorded in our data.
IFLb is an independent medical laboratory located in Berlin, Germany. They have been providing clinical and research services for over 35 years, with a focus on metabolomics for chronic kidney disease. They offer online test result access and other services through their website.
IFLb has 1 investor. Key investors include Medicover.
IFLb operates through Iflb Laboratoriumsmedizin Berlin Gmbh.
Yes. IFLb was acquired by Medicover in January 2024.